Zobrazeno 1 - 10 of 24 pro vyhledávání: '"M. Kluibenschaedl"'
1
Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis
Autor: Jerald P. Radich, Kuo Kuan-Ling, Ursula Rochau, Diana I. Brixner, M. Kluibenschaedl, David D. Stenehjem, Gary M. Oderda, Uwe Siebert
Publikováno v: Leukemia Research and Treatment
Currently several tyrosine kinase inhibitors (TKIs) are approved for treatment of chronic myeloid leukemia (CML). Our goal was to identify the optimal sequential treatment strategy in terms of effectiveness and cost-effectiveness for CML patients wit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::629444df8a34fa5dddca07a6291e1db5
https://pubmed.ncbi.nlm.nih.gov/26783469
Zobrazit plný text záznamu
3
Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
Autor: Jerald P. Radich, David D. Stenehjem, Diana I. Brixner, M. Kluibenschaedl, Uwe Siebert, Ursula Rochau, Günther Gastl, Beate Jahn, Dominik Wolf, Stefan Schmidt, Annette Conrads-Frank, Gaby Sroczynski
Publikováno v: Leukemialymphoma. 56(8)
Several tyrosine kinase inhibitors (TKIs) are approved for chronic myeloid leukemia (CML) therapy. We evaluated the long-term cost-effectiveness of seven sequential therapy regimens for CML in Austria. A cost-effectiveness analysis was performed usin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e998e7434063826ddef89c2c6d83d63
https://pubmed.ncbi.nlm.nih.gov/25393806
Zobrazit plný text záznamu
4
Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an example
Autor: Ursula Rochau, Uwe Siebert, Günther Gastl, Christina Kurzthaler, Wolfgang Willenbacher, V. Qerimi, Ella Willenbacher, Beate Jahn, M. Kluibenschaedl, Emily A. Burger
Publikováno v: Critical reviews in oncology/hematology. 94(2)
Purpose The purpose of this study was to provide a clinician-friendly overview of decision-analytic models evaluating different treatment strategies for multiple myeloma (MM). Methods We performed a systematic literature search to identify studies ev
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a0a7abad20637ab918d4102284cff1d
https://pubmed.ncbi.nlm.nih.gov/25620327
Zobrazit plný text záznamu
5
Systematic assessment of decision-analytic models for chronic myeloid leukemia
Autor: Guenther Gastl, Ursula Rochau, Diana I. Brixner, Gaby Sroczynski, Jerald P. Radich, Ruth Schwarzer, Dominik Wolf, Uwe Siebert, M. Kluibenschaedl, Beate Jahn
Publikováno v: Applied health economics and health policy. 12(2)
Several tyrosine kinase inhibitors (TKIs) are approved for the treatment of chronic myeloid leukemia (CML). Decision-analytic modeling can help to extrapolate data from short-term clinical trials and also consider quality of life when evaluating diff
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dbd5122a55d8900f103885175e0ad72
https://pubmed.ncbi.nlm.nih.gov/24385259
Zobrazit plný text záznamu
9
Methodological Characteristics Of Decision-Analytic Modeling Studies For The Treatment Of Multiple Myeloma
Autor: Ursula Rochau, Vjollca Querimi, Beate Jahn, Annette Conrads-Frank, M. Kluibenschaedl, Wolfgang Willenbacher, Christina Kurzthaler, Guenther Gastl, Ella Willenbacher, Uwe Siebert
Publikováno v: Blood. 122:2991-2991
Purpose (1)To give an overview on published decision-analytic models evaluating treatment strategies in multiple myeloma with a focus on methodological aspects of modeling approaches. (2) To derive recommendations for future decision-analytic models
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f446b1680782265bb55f5fdafb769309
https://doi.org/10.1182/blood.v122.21.2991.2991
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje